Followers | 104 |
Posts | 2500 |
Boards Moderated | 0 |
Alias Born | 12/02/2016 |
Friday, February 05, 2021 11:47:27 PM
I'd like to know your thoughts on whether you believe the current surge in TXTM stock is somewhat related to the Canopy and GW Pharma lawsuit vis-a-vis extraction technology.
https://www.marijuanamoment.net/canopy-growth-says-gw-pharma-infringed-on-cbd-extraction-patent-in-federal-lawsuit/
It's my understanding that this lawsuit could have widespread implications for all cannabis companies that use C02 extraction. As you know, TXTM employs a proprietary and patented live plant ( non C02 )extraction technology.
C02 extractors will face the risk of litigation if the courts side with Canopy. So, cannabis companies will either pay the licensing for C02 extraction or seek out other extraction technologies.
Things could get interesting in a big way. Never know who might pick up $TXTM for their live plant extraction patent.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM